Resmed Inc. buy CLSA
Start price
02.09.25
/
50%
€232.70
Target price
02.09.26
-
Performance (%)
-17.04%
Price
20:00
€193.05
Summary
This prediction is currently active. The prediction for Resmed Inc. disappoints with a performance of -17.04%. This prediction currently runs until 02.09.26. The prediction end date can be changed by CLSA at any time. CLSA has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Resmed Inc. | 5.421% | 5.421% |
| iShares Core DAX® | 3,26 % | 2,07 % |
| iShares Nasdaq 100 | 5,70 % | -0,60 % |
| iShares Nikkei 225® | 7,77 % | -4,75 % |
| iShares S&P 500 | 2,80 % | 2,25 % |
Comments by CLSA for this prediction
In the thread Resmed Inc. diskutieren
ResMed (NYSE:RMD) was upgraded by analysts at CLSA from a "hold" rating to an "outperform" rating.
Ratings data for RMD provided by MarketBeat